Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis

Condition:   Breast Tumors Intervention:   Drug: DS-8201a Sponsors:   UNICANCER;   Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials